Literature DB >> 25621020

Determination of Methylarginines in Infant Plasma by CE-LIF.

Thomas H Linz1, Susan M Lunte2.   

Abstract

Methylarginines (MAs) are a class of nitric oxide synthase inhibitors that have been implicated in respiratory complications of critically ill infants. This paper describes the development of an analytical method to measure these compounds in the plasma of newborns using capillary electrophoresis (CE). The CE separation method was optimized to enable complete baseline resolution of the four MA analogues of interest. Sample preparation concerns for infant-derived samples were addressed by validating a heat-assisted extraction method for the analysis of low volume (≤100 µL) samples from a plasma matrix. It was determined that the sample matrix (plasma versus serum) did not affect the measured MA concentrations, while extracting smaller volumes of plasma that underwent heat-induced gelation afforded higher MA recoveries than larger volume samples. These methods were then applied to blood samples collected from infants housed in the neonatal intensive care unit. It was discovered that these newborns had significantly elevated concentrations of MAs at younger ages (< 6 months) while amounts were similar between infants 6 months old and adults. The data are preliminary, but demonstrate an interesting age dependence on the concentrations of these nitric oxide inhibitors, which has not been previously reported.

Entities:  

Year:  2014        PMID: 25621020      PMCID: PMC4303571          DOI: 10.1039/C4AY00340C

Source DB:  PubMed          Journal:  Anal Methods        ISSN: 1759-9660            Impact factor:   2.896


  18 in total

Review 1.  Colorimetric protein assay techniques.

Authors:  C V Sapan; R L Lundblad; N C Price
Journal:  Biotechnol Appl Biochem       Date:  1999-04       Impact factor: 2.431

2.  Asymmetric dimethylarginine in ELBW newborns exposed to chorioamnionitis.

Authors:  Michela Alfiero Bordigato; Daniele Piva; Iole Maria Di Gangi; Giuseppe Giordano; Lino Chiandetti; Marco Filippone
Journal:  Early Hum Dev       Date:  2010-12-08       Impact factor: 2.079

3.  Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine.

Authors:  Mariska Davids; Albert J van Hell; Marlieke Visser; Robert J Nijveldt; Paul A M van Leeuwen; Tom Teerlink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-02-24       Impact factor: 4.733

4.  Heat-assisted extraction for the determination of methylarginines in serum by CE.

Authors:  Thomas H Linz; Susan M Lunte
Journal:  Electrophoresis       Date:  2013-06       Impact factor: 3.535

Review 5.  Perinatal endocrinology: common endocrine disorders in the sick and premature newborn.

Authors:  Sharon J Hyman; Yeray Novoa; Ian Holzman
Journal:  Pediatr Clin North Am       Date:  2011-10       Impact factor: 3.278

Review 6.  The lung in the balance: arginine, methylated arginines, and nitric oxide.

Authors:  Raed A Dweik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-09-15       Impact factor: 5.464

7.  Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.

Authors:  Zeneng Wang; W H Wilson Tang; Leslie Cho; Danielle M Brennan; Stanley L Hazen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-06-18       Impact factor: 8.311

8.  Comparative analysis of sample preparation methods to handle the complexity of the blood fluid metabolome: when less is more.

Authors:  Sara Tulipani; Rafael Llorach; Mireia Urpi-Sarda; Cristina Andres-Lacueva
Journal:  Anal Chem       Date:  2012-12-14       Impact factor: 6.986

Review 9.  Laboratory screening for genetic disorders and birth defects.

Authors:  F J Bamforth
Journal:  Clin Biochem       Date:  1994-10       Impact factor: 3.281

Review 10.  From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases.

Authors:  Dariusz Zakrzewicz; Oliver Eickelberg
Journal:  BMC Pulm Med       Date:  2009-01-29       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.